Data News > Underperform Recommendation Issued On GMO By UBS
UBS analyst issues UNDERPERFORM recommendation for GMO on May 31, 2024 01:00PM ET. The previous analyst recommendation was Underperform. GMO was trading at $0 at issue of the analyst recommendation. The overall analyst consensus : STRONG BUY. Current analyst recommendations are : recommendations .
For more information:
Analyst Recommendations Historical Price Targets Earning Price Impact Analysis Seasonality Analysis
Underperform Recommendation Issued On GMO By UBS
By KlickAnalytics Data Insights | May 31, 2024 02:15PM ET
Historical Analyst Recommendations
Latest 10 recommendationsReport Date | Analyst Company | Action | Previous Grade | New Grade | Price when posted | 2024-05-31 | UBS | Hold | Underperform | Underperform | 0.00 | 2024-05-03 | UBS | Hold | Underperform | Underperform | 0.00 | 2024-03-04 | UBS | Hold | Underperform | Underperform | 0.00 | 2024-02-12 | Truist Financial | Hold | Underperform | Underperform | 0.00 | 2024-01-05 | Oppenheimer | Hold | Underperform | Underperform | 0.00 |
Historical Price Performance
For more information:
This article was generated by KlickAnalytics data insight content engine.
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.